• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Lupin receives tentative FDA approval for Raltegravir tablets

    EXPRESSPHARMA

    Generic HIV raltegravir medicines approved

    EUROPEAN PHARMACEUTICAL REVIEW

    FDA Confirms Paragraph IV Patent Litigation for Raltegravir Potassium Tablets

    FDA

    Roche, Merck, Novartis and others hike prices on 83 meds starting in July

    FIERCE PHARMA

    US FDA approves Merck`s once-daily dose of Isentress in combo

    PHARMABIZ

    Merck shops for hefty M&A amid `uninspiring` Q1 for new meds

    FIERCE PHARMA

    Merck’s phase 3 study of once-daily Isentress in HIV-1 adults meet endpoints

    PHARMABIZ

    GSK`s HIV bright spot could get brighter with new Tivicay combo meds

    FIERCE PHARMA MARKETING

    Merck Grants Free License For Pediatric HIV Drug

    PHILLY.COM

    Merck Sharp Dohme`s Dutrebis (Lamivudine 150Mg /Raltegravir 300Mg) Approved in USA for HIV-1 Infection

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.